{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OAR-2006-0159-0043", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for CONFIDENTIAL supplementary information received by EPA from Robert M. Sussman of Latham and Watkins, LLC, council for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on February 22, 2007", "Supporting & Related Material", "Other", "2007-02-27T05:00:00Z", 2007, 2, null, null, "2007-02-27T18:26:42Z", null, 0, 0, "090000648020bd6b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OAR-2006-0159-0043"], "units": {}, "query_ms": 35.47594998963177, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}